New Mexico Register / Volume XXX, Issue 17 / September 10, 2019

NOTICE OF REGULAR BOARD MEETING AND RULE HEARING

The New Mexico Board of Pharmacy will convene on October 24th & 25th, 2019 at 9:00 a.m. and continue until finished in the Board of Pharmacy Conference Room located at 5500 San Antonio Dr., NE, Albuquerque, NM 87109 for the purpose of conducting a regular board meeting.

The agenda is posted 72 hours prior to the scheduled meeting. You may view and download a copy of the agenda through the board’s website: www.rld.state.nm.us/boards/pharmacy.aspx. All proposed language regarding rule hearings is linked on the Agenda, the Notice to the Public on our website and the New Mexico Sunshine Portal.

Individuals petitioning the board regarding requests/waivers and/or interested persons wishing to comment on proposed language regarding rule hearings must submit documentation for presentation; via fax (505) 222-9845, mail or email to the Executive Director, Cheranne McCracken, Cheranne.McCracken@state.nm.us at least one week in advance to the scheduled meeting, if in attendance must also provide 12 copies of that documentation for distribution to board members and staff, as public comment is allowed during the rule hearing. (Board staff is not required to make copies.)

The board may go into Executive Session to discuss items pursuant to Section 10-15-1H(1), Section 10-15-1H(2), Section 10-15-1H(3) or Section 10-15-1H(7) of the Open Meeting Act. Agenda items may be executed at any time during the meeting to accommodate hearings.

If you are an individual with a disability who is in need of a reader, amplifier, qualified sign language interpreter, or any other form of auxiliary aid or service to attend or participate in the hearing or meeting, please contact Kristina Benavidez at 505-222-9878 at least one week prior to the meeting or as soon as possible. Public documents, including the agenda and minutes, can be provided in various accessible formats. Please contact Kristina Benavidez, at 505-222-9878 or e-mail kristina.benavidez@state.nm.us if a summary or other type of accessible format is needed.

The Board will address:

All Board Matters:

Rule Hearings:

16.19.18 NMAC – NUCLEAR PHARMACY: Amendments to Sections 1, 3, 7, 9, and 10; administrative updates - board address, citation format; Section 7, update training requirements consistent with current standards and training availability; Section 9, allow paper or electronic records, require equipment as applicable to the scope of nuclear pharmacy services provided, and recognize required standards of USP <825> and applicable general chapters numbered 1000 or less. Section 10, delete obsolete citation.

STATUTORY AUTHORITY: Paragraphs (1) (3) and (6) of Subsection (A) of Section 61-11-6 NMSA 1978

16.19.20 NMAC – CONTROLLED SUBSTANCES: Amendments to Sections 9, 16, 20, 26, 36, 37, 38, 40, 41, 53, 65, 66, and 69; administrative updates – renewal applications may be sent to physical, mailing or electronic address, clarify section title, update alpha to numeric; Section 20 update and clarify inventory requirements; Section 37 update and clarify disposal of controlled substance waste process; Section 38, update and clarify disposition of unusable, outdated or unwanted controlled substance processes; Section 41, update to allow prescribing of narcotic controlled drug for dependence when approved by the FDA specifically for use in maintenance or detoxification; Section 65, add phenazepam to list of Schedule I controlled substances; Section 66, add dronabinol in an oral solution in a drug approved for marketing by the FDA to Schedule II controlled substance list; Section 69, add brivaracetam and drug product approved by the FDA and which contains cannabidiol derived from cannabis and no more than 0.1 percent tetrahydrocannabinols to the Schedule V controlled substance list.

STATUTORY AUTHORITY: Sections 30-31-1 through 30-31-42 NMSA 1978

Disciplinary Hearings: note – the information below is tentative. Final hearing date and time for each case will be included in the agenda posted to the board’s website at least 72 hours before the meeting.

10/24/19 @ 1:30 p.m. - Tom White RP 3712, PC 204, TW Wellness PH 4187 - case 2017-021

*Additional hearing(s), if scheduled, will be included in the agenda

Executive Director’s Report:

Published in Albuquerque Journal September 10, 2019

Published in NM Register September 10, 2019